BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35107655)

  • 1. Symptom burden profiles in men with advanced prostate cancer undergoing androgen deprivation therapy.
    Noriega Esquives B; Lee TK; Moreno PI; Fox RS; Yanez B; Miller GE; Estabrook R; Begale MJ; Flury SC; Perry K; Kundu SD; Penedo FJ
    J Behav Med; 2022 Jun; 45(3):366-377. PubMed ID: 35107655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy.
    Benedict C; Traeger L; Dahn JR; Antoni M; Zhou ES; Bustillo N; Penedo FJ
    J Sex Med; 2014 Oct; 11(10):2571-80. PubMed ID: 25059094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
    Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
    Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The perspective of prostate cancer patients and patients' partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples.
    Hamilton LD; Van Dam D; Wassersug RJ
    Psychooncology; 2016 Jul; 25(7):823-31. PubMed ID: 26411285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
    Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial interventions for men with prostate cancer.
    Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008529. PubMed ID: 24368598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function.
    Joyce DD; Wallis CJD; Luckenbaugh AN; Huelster HL; Zhao Z; Hoffman KE; Huang LC; Koyama T; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; Neil BBO; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):238-247. PubMed ID: 34108648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Kilgour A; Lau YK
    BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study).
    Green A; Newton RU; Smith DP; Tuffaha H; Galvão DA; Heathcote P; Patel MI; Christie D; Egger S; Sara SA; Heneka N; Chambers SK; Dunn J
    BMJ Open; 2024 Mar; 14(3):e084412. PubMed ID: 38521521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
    Siebert AL; Lapping-Carr L; Morgans AK
    Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.
    Cary KC; Singla N; Cowan JE; Carroll PR; Cooperberg MR
    J Urol; 2014 Apr; 191(4):964-70. PubMed ID: 24184370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
    Lubeck DP; Grossfeld GD; Carroll PR
    Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial interventions for men with prostate cancer: a Cochrane systematic review.
    Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
    BJU Int; 2015 Aug; 116(2):174-83. PubMed ID: 25429987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.
    Wilding S; Downing A; Wright P; Selby P; Watson E; Wagland R; Donnelly DW; Hounsome L; Butcher H; Mason M; Henry A; Gavin A; Glaser AW
    Qual Life Res; 2019 Oct; 28(10):2741-2751. PubMed ID: 31115843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
    Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
    J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy.
    Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song H
    Eur J Oncol Nurs; 2017 Oct; 30():84-90. PubMed ID: 29031319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials.
    Teleni L; Chan RJ; Chan A; Isenring EA; Vela I; Inder WJ; McCarthy AL
    Endocr Relat Cancer; 2016 Feb; 23(2):101-12. PubMed ID: 26584972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom and function profiles of men with localized prostate cancer.
    Reeve BB; Tan X; Chen RC; Usinger DS; Pinheiro LC
    Cancer; 2018 Jul; 124(13):2832-2840. PubMed ID: 29660795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
    Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW
    Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.
    Saini A; Berruti A; Cracco C; Sguazzotti E; Porpiglia F; Russo L; Bertaglia V; Picci RL; Negro M; Tosco A; Campagna S; Scarpa RM; Dogliotti L; Furlan PM; Ostacoli L
    Urol Oncol; 2013 Apr; 31(3):352-8. PubMed ID: 21803612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.